SAFC expands PharmaGrade raw materials portfolio
PharmaGrade Portfolio expected to double in 2013 to meet growing demand
SAFC is expanding its line of PharmaGrade products with the addition of 20 raw materials for biopharmaceutical manufacturing. The PharmaGrade portfolio of high quality buffers, amino acids and speciality chemicals is expected to double in size by the end of 2013.
PharmaGrade addresses the need for greater supply chain transparency and enhanced quality for biopharmaceutical manufacturing applications. Products in the PharmaGrade portfolio are provided with full documentation of manufacturing history, are compliant with either GMP standards or the SAFC Elite Quality grade standards, and are quality assurance reviewed and released. PharmaGrade products also include applicable change control notification and a dedicated product support team.
Having begun with more than 30 products at its launch in early 2012, the PharmaGrade programme has continued to grow steadily and is expected to reach 80 raw materials by the end of March 2013. Sigma-Aldrich's acquisition of Research Organics in April 2012 contributed significantly to the programme's resources and capabilities to further support the increasing market demand for new PharmaGrade materials.
‘The introduction of the PharmaGrade portfolio was designed to meet the growing need for greater transparency for raw materials,’ said Deb Slagle, Vice President of Marketing and Research Development at SAFC. ‘The acquisition of Research Organics has accelerated our ability to add products more rapidly and significantly contributed to the overall success of the portfolio.’
‘PharmaGrade is a clear reflection of our drive to offer quality products in tandem with exceptional customer support,’ added Gilles Cottier, President of SAFC. ‘We continue to apply all feedback to the further development of the line, and will continue to expand the PharmaGrade portfolio in a strategic manner.’
